Table 3.

Number of patients with endoscopic diagnosis; sensitivity, specificity, PPV and NPV as GBS increases

GBSPathology (n=304)SensitivitySpecificityPPVNPV
035 (56.45%)88.90% (84.35–91.85)27.85% (19.21–37.85)79.35% (77.14–81.40)43.55% (33.04–54.67)
≤157 (55.34%)81.25% (76.40–85.48)48.42% (38.04–58.90)83.45% (80.46–86.05)44.66% (37.12–52.46)
≤278 (58.78%)74.34% (69.05–79.16)61.05% (50.50–70.89)85.93% (82.48–88.79)42.65% (36.68–48.84)
≤395 (58.78%)68.75% (63.21–73.92)71.58%(61.40–80.36)88.56% (84.79–91.49)41.72% (36.73–46.88)
≤4115 (60.85%)62.17% (56.46–67.64)77.89 % (68.22–85.77)90.00% (85.93–92.99)39.15% (34.97–43.50)
≤5134 (53.81%)55.92% (50.14–61.58)80.00% (70.54–87.51)89.95% (85.53–93.12)36.19% (32.55–40.00)
≤6146 (65.47%)51.97%(46.20–57.71)81.05% (71.72–88.37)89.77% (85.10–93.10)34.53% (31.18–38.04)
≤7172 (66.15%)43.42% (37.77–49.20)92.63% (85.41–96.99)94.96% (90.14–97.49)33.85% (31.35–36.44)
≤8191 (67.77%)37.17%(31.72–42.87)95.79% (89.57–98.84)96.58% (91.46–96.68)32.27% (30.20–34.41)
  • GBS = Glasgow Blatchford score; NPV = negative predictive value; PPV = positive predictive value